LRP6 and esophageal squamous cell carcinoma: In contrast, the abilities were partially recovered when cells were co‐transfection with miR‐590 inhibitor or simultaneously overexpressed LRP6, indicating that ESCCAL‐1 regulated the miR‐590/ LRP6 axis to promote ESCC progression in vitro (Figure 6A–D).